CME Online: Management of immune-related adverse effects in lung cancer

8 May, 2019

A new CME Online module that looks at how to manage immune-related adverse effects in lung cancer patients under immunotherapy is now available.

Led by Dr Torsten Gerriet Blum and Prof. David Baldwin, this module includes two interactive case simulations and an engaging panel discussion, which will teach participants to:

  • Estimate the risk for immune-related adverse effects in lung cancer patients under an immunotherapy with checkpoint-inhibitors;
  • Identify the general spectrum of immune-related adverse effects in lung cancer caused by checkpoint-inhibitors;
  • Discuss the management of these side effects and specific kinetics of appearance and resolution;
  • Diagnose and manage specifically pulmonary complications in lung cancer patients under an immunotherapy with checkpoint-inhibitors.

Participants with a myERS account will also be able to take a test on the topic at the end of the module, which is accredited with one CME credit. A CME certificate will be awarded upon successful completion of the CME test.

Take the module
Access more online modules